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SUMMARY
Regioselective facile synthesis of innovative hetero-
cycles from the reaction of 2-cyano-N-cyclohexylacet-
amide (3) with N, N- dimethylformamide dimethyl 
acetal (DMF-DMA) to afford (E)-2-cyano-N-cyclohex-
yl-3-(dimethylamino)acrylamide (4) under microwave 
irradiation.  Enaminonitrile 4 reacts with hydrazine 
derivatives affords the corresponding pyrazole deriva-
tives 5a-c, furthermore the behavior of enaminone 
4 reacts with guanidine to give the corresponding 
2,4 diaminopyrimidine derivative (7). Moreover (E)-
2-cyano-N-cyclohexyl-3-(dimethylamino) acrylamide 
(4) reacts with amino pyrazoles 8a-f, 1,2,4-aminotri-
azole (11) and 2-aminobenzimidazole (13) to afford 
the corresponding pyrazolo[1,5-a]pyrimidine 9a-f, and 
triazolo[4,3-a]pyrimidine 12, pyrimido[1,2-a]benzim-
dazole 14; respectively. Density functional theory cal-
culations at the B3LYP/6-31G (d) levels of theory have 
been carried out to investigate the equilibrium geom-
etry of the novel fused pyrazoles 5a and 9a. Moreover, 
the total energy, the energy of the HOMO and LUMO 
and Mulliken atomic charges were considered. Addi-
tionally, the measurements of their interactions with 
hydrazine hydrate to form fused pyrazoles 5a and 9a 
have been calculated. Also, comprehensive theoretical 
and experimental structural studies of 7-amino-N-
cyclohexyl-2-methyl-3-phenylpyrazole[1,5-a]pyrim-
idine-6-carboxamide (9a) have been carried out by 
elemental analysis, FTIR, 1H NMR and Mass. Opti-
mized molecular structure and harmonic vibrational 
frequencies have been reconnoitered by DFT/B3LYP 
and HF methods  combined with 6-31G(d) basis set.
Keywords: Enaminonitrile; cyclohexylamine; ami-
nopyrazole; aminopyrimidine; triazole [4,3-a] py-
rimidine; pyrazolo[1,5-a]pyrimidine;  pyrimido[1,2-a]
benzimidazole; DFT calculations.
RESUMEN
Síntesis regioselectiva simple de los heterociclos 
innovadores de la reacción del 2-ciano-N-ciclohexi-
lacetamida (3) con N, N- dimetilformamida dimetil 
acetal (DMF-DMA) para conseguir (E)-2-ciano-N-
ciclohexil-3-(dimetilamino) acrilamida (4) en una 
irradiación por microondas. La enaminonitrilo 4 re-
acciona con los derivados de hidracina para dar los 
correspondientes derivados de pirazol 5a-c, de for-
ma que la enaminona 4 reacciona con la guanidina 
para dar el correspondiente derivado 2,4 diamino-
pirimidina (7). Además, la (E)-2-ciano-N-ciclohexil-
3-(dimetilamino) acrilamida (4) reacciona con los 
aminopirazoles 8a-f, 1,2,4-aminotriazol (11) y 2-ami-
nobenzimidazol (13) para obtener el correspon-
diente pirazol[1,5-a]pirimidina 9a-f, el triazol[4,3-a]
pirimidina 12, y el pirimido[1,2-a]bencimidazol 14, 
respectivamente. Se han llevado a cabo cálculos de 
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la teoría del funcional de la densidad a niveles teóri-
cos de B3LYP/6-31G (d) para investigar la geometría 
del equilibrio de los nuevos pirazoles fundidos 5a y 
9a. Además se han tenido en cuenta la energía total, 
la energía del HOMO y LUMO y las cargas atómi-
cas de Mulliken. Adicionalmente,  se han calculado 
las mediciones de sus interacciones con hidratos de 
hidracina para formar pirazoles fundidos 5a y 9a. 
Asimismo también se han realizado detallados es-
tudios estructurales, teóricos y experimentales, del 
7-amino-N-ciclohexil-2-metil-3-fenilpirazol[1,5-a]
pirimidina-6-carboxamida (9a) mediante análisis ele-
mental, FTIR, 1H NMR y espectroscopia de masas. La 
estructura molecular optimizada y las frecuencias vi-
bracionales armónicas han sido exploradas mediante 
los métodos DFT/B3LYP y HF en combinación con el 
equipo de base 6-31G(d).
Palabras clave: Enaminonitrilo; ciclohexilamina; 
aminopirazol; aminopirimidina; triazol [4,3-a] piri-
midina; pirazol[1,5-a]pirimidina; pirimido[1,2-a]ben-
cimidazol;, cálculos de la DFT.
RESUM
Síntesi regioselectiva simple dels heterocíclics innova-
dors de la reacció del 2-ciano-N-ciclohexilacetamida (3) 
amb N, N- dimetilformamida dimetil acetal(DMF-D-
MA) per aconseguir (E)-2-ciano-N-ciclohexil-3-(dime-
tilamino)acrilamida (4) en una irradiació per microones. 
La enaminonitrilo 4 reacciona amb els derivats de la 
hidrazina per donar resultat als corresponents derivats 
de pirazol 5a-c, de forma que la enaminona 4 reaccio-
na amb la guanidina per obtenir el corresponent derivat 
2,4 diaminopirimidina (7). D’altra banda, la (E)-2-cia-
no-N-ciclohexil-3-(dimetilamino) acrilamida (4) reacci-
ona amb els aminopirazoles 8a-f, 1,2,4-aminotriazol (11) 
i 2-aminobenzimidazol (13) per obtenir el corresponent 
pirazol[1,5-a]pirimidina 9a-f, el triazol[4,3-a]pirimidina 
12, i el pirimido[1,2-a]bencimidazol 14 respectivament. 
S’han portat a terme càlculs de la teoria del funcional de la 
densitat a nivells teòrics del B3LYP/6-31G (d) per investi-
gar la geometria del equilibri dels nous pirazols fosos 5a 
i 9a. A més a més s’ha tingut en compte la energia total, 
la energia del HOMO i LUMO i les carreges atòmiques 
de Mulliken. Addicionalment, s’han calculat les mesures 
de les seves interaccions amb hidrats de hidrazina per 
formar els pirazols fosos 5a i 9a. Al mateix temps també 
s’han realitzat estudis estructurals detallats, teòrics i ex-
perimentals, del 7-amino-N-ciclohexil-2-metil-3-fenil-
pirazol[1,5-a]pirimidina-6-carboxamida (9a) per mitjà 
del anàlisi elemental, FTIR, 1H NMR i la espectroscòpia 
de massa. La estructura molecular optimitzada i les fre-
qüències vibracionals harmòniques han sigut explorades 
per mitjà dels mètodes DFT/B3LYP i HF en combinació 
amb l’equip de base 6-31G(d).
Paraules clau: Enaminonitrilo; ciclohexilamina; 
aminopirazol; aminopirimidina; triazol [4,3-a] piri-
midina; pirazol[1,5-a]pirimidina; pirimido[1,2-a]ben-
cimidazol;, càlculs de la DFT.
INTRODUCTION
The class of cyclohexylamine derivatives excludes 
acetylcholinesterase inhibitors1, 2, activators of dopa-
mine receptors in the CNS3, and highly active-opioid 
analgesics4. The innovation of the psychotomimetic 
action of the recognized analgesic drug phencycli-
dine5 has expanded investigations devoted to the 
synthesis and pharmacological characterization of 
numerous derivatives of cyclohexylamine6-10. Cyano-
acetamide derivatives are extremely reactive, poly-
functional compounds that possess both electrophilic 
and nucleophilic centers. Cyanoacetamide is accom-
plished of dimerization once heated in alkaline me-
dium. Two of the nucleophilic centers in cyanoaceta-
mides are localized on the NH and the C-2 positions 
with a reactivity order C-2 > NH. Two electrophilic 
positions are accompanying with the C-1 and C-3 
positions with reactivity order C-3 > C-1 (Figure. 
1)11-13. Cyanoacetamide derivatives are commonly 
used as active synthons for the syntheses of many 
open-chain systems and polysubstituted heterocyclic 
compounds14-15. Cyanoacetamide chemical properties 
have been used to design various heterocyclic moie-
ties with different ring sizes. The occurrence of two 
electron-withdrawing groups’ outcomes in the high 
activity of cyanoacetamides as CH acidic and the ac-
tive methylene means they can cooperate in a varia-









Figure 1. Cyanoacetamide derivatives reactivity 
Moreover, their carbonyl and the cyano function-
al groups facilitate them to react with common re-
agents to form a variety of heterocyclic compounds 
such as thiophene20, pyrazole17, thiazole17-19, 1,3-dithi-
azole, 1,3-dithiane13, pyridine13-17, chromene and cou-
marin derivatives13-15. Furthermore, cyanoacetamide 
derivatives were exploited as key precursors for the 
synthesis of polycondensed heterocyclic compounds 
such as pyrazolo [1,5-a]pyrimidine13, pyrano[3,2-
g]-chromene13, pyrazolo [3,4-b] pyrazines20 and thi-
azolo[3,2-a]pyridines21. Upon a comprehensive survey 
of the methods for the preparation and chemical re-
activity of cyanoacetamide derivatives, we found that 
the synthesis of cyanoacetamides could be carried out 
in several ways. The most adaptable and commonly 
used preparative method is the acylation of aromatic 
or heterocyclic amines with ethyl cyanoacetate under 
various reaction conditions17, 22. The enaminonitrile 
(E)-2-cyano-N-cyclohexyl-3-(dimethylamino) acryla-
mide (4) hasn’t described in literature hitherto, which 
used for the synthesis of heterocyclic compounds 
pendant with-N-cyclohexyl amide moiety of expected 
biological activity23-25. Moreover, microwave irradia-
tion has been recently demonstrated its utility as an 
energy source to improve yields and/or save reaction 
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condition, especially in the field of heterocyclic syn-
thesis26-28. Our concern of research designates simple 
and efficient route for the synthesis of novel pyrim-
idine carboxamide, pyrazolo pyrimidine, triazole 
pyrimidine carboxamide, benzimidazole pyrimidine 
derivatives. derivatives interacting cyclohexyl moiety 
utilizing microwave irradiation. Density functional 
theory (DFT) has been improved in theoretical mod-
eling. Different computational techniques can predict 
the chemical and physical properties of biological and 
chemical systems29-35. Herein, we executed theoretical 
studies on the most encouraging compounds 5a and 
9a utilizing DFT/B3LYP/6-31G (d) method. 
EXPERIMENTAL
Materials and methods
All melting points were measured with a Gallen-
kamp melting point apparatus. IR spectra were re-
corded on Shimadzu FT-IR 8101 PC infrared spec-
trophotometer. The  1H-NMR and 13C-NMR spectra 
were determined in CDCl3 or DMSO-d6 at 300 MHz 
on a Varian Mercury VX 300 NMR spectrometer 
(1H at 300 MHz, 13C at 75 MHz) using TMS as an 
internal standard. Mass spectra were recorded on a 
Shimadzu GCMS-QP 1000 EX mass spectrometer at 
70 eV. Elemental analyses were carried out at the Mi-
cro analytical Center of Cairo University, Giza, Egypt. 
Microwave experiments were carried out using CEM 
Discover TM microwave apparatus.
Material and reagents
Cyclohexylamine, ethyl cyanoacetate, dimethyl-
formamide dimethyl acetal (DMF-DMA), hydrazine 
hydrate, phenyl hydrazine, triethylamine, 2-amino 
benzimidazole, aminopyrazole, and aminotriazole 
were purchased from Aldrich Chemical CO. Etha-
nol, and pyridine, toluene, THF, piperidine purchased 
from Aldrich Chemical CO. Methanol, isopropyl al-
cohol, petroleum ether; chloroform where BDH re-
agents were purchased from EL-Nasr Pharmaceutical 
and Chemical Co. (ADWIC), Egypt.
Synthesis of (E)-2-cyano-N-cyclohexyl-3- (di-
methylamino) acrylamide (4)
To a solution of 2-cyano-N-cyclohexylacetamide36-37 
(3) (10g, 10mmol) in dry toluene or without solvent 
was added dimethylformamide-dimethyl acetal 
(DMF-DMA) (10ml,12 mmol) and the mixture was 
mixed in an HP-500 Plus process vessel. The vessel 
was capped properly and irradiated by microwaves 
under pressurized conditions (17.2 bar, 110oC) for 
10 min. The excess DMF-DMA was evaporated in 
vacuo and the residue was dissolved in diethylether 
(50 ml) and dried over MgSO4. After evaporation 
of the solvent the subsequent solid was recrystal-
lized in ethanol to give (E)-2-cyano-N-cyclohexyl-
3-(dimethylamino)acrylamide (4) with  yield 75% 
; m.p 140-142ºC, ; IR (KBr) νmax/cm-1:  1656 (C=O), 
3342  (NH), 2186 (C=N), cm-1; 1H NMR (DMSO d6): 
1.4-1.7 (m, 10H, H2C), 3.09(s, 6H, H3CH), 3.51(s,1H, 
HC-NH), 6.58(d, 1H, HC, J=2.7Hz), 7.66(s, 1H, HN 
D2Oexchangeable) ; 13C NMR (75MHz, DMSO-d6) d 
22.9 (CH2), 28(CH2), 33.8 (CH2), 42.3(CH3), 46.9(CH), 
98.8 (CH), 115.9 (CN), 156.1 (CH=), 159(C=O); MS 
m/z (%)123(M+, 100.0%), 221(34.8%), 163 (16.4%), 53 
(23.2%), Anal calcd  C12H19N3O (221.13) : C, 65.13; H, 
8.65;  N,18.99 % ;Found: C,65.10; H, 8.68; N,19.03%; 
Reactions of Enamonitrile 4 with hydrazine 
hydrate derivatives:
General procedure
Thermal method: Enaminonitrile 4 (0.44g, 2mmol) 
in isopropyl alcohol (20ml), hydrazine hydrate 80% 
(0.2ml, 2mmol), phenyl hydrazine (0.2ml, l) and 
phenyl sulfahydrazine (0.344g, 2 mmol) was add-
ed. The resulting mixture was refluxed for 4h and 
observed by TLC and then allowed to cool the sol-
id formed was filtered off and washed with ethanol 
and dried. Recrystallization from ethanol afford-
ed the corresponding pyrazoles derivatives 5a-c. 
Microwave method: To a solution of Enaminonitrile 
4 (.44g , 2mmol) in isopropyl alcohol (20ml),  hydra-
zine hydrate80%,  (0.2ml, 2mmol), phenyl hydrazine 
(0.2ml,) and phenyl sulfa hydrazine (0.344 g, 2mmol) 
was added. The reaction mixture was mixed in a HP-
500 Plus process vessel. The vessel was capped prop-
erly and irradiated by microwaves under pressurized 
conditions (17.2 bar, 130oC) for 20 min (examined by 
TLC), the cooled the solid formed was filtered off and 
washed by ethanol and dried. Recrystallization from 
ethanol afforded the corresponding pyrazoles deriv-
atives 5a-c 
5-amino-N-cyclohexyl-1H-pyrazole-4-carbox-
amide (5a) yield 85 %; mp=214-216 oC ; IR (KBr) 
νmax/cm-1: 1646 (C=O), 3409(NH), 3336(NH2) cm-1; 
1H NMR (DMSO d6): d1.3-1.8(m, 10H, H2C), 3.53(s, 
1H, HC-NH), 6.37(s, 2H, H2ND2O-exchangable), 7.85 
(s,1H, HND2O-exchangable ),7.96 (s, 1H, HC),13.2 (s, 
1H, HN D2O-exchangable pyrazole), 13CNMR(300M-
Hz, DMSO-d6) d 22.9(CH2), 28(CH2), 33.8(CH2), 
47.1(CH), 114.5(CH2), 144.6(CH), 154(CH=), 167.3 
(C=O); MS m/z (%) 208 (M+, 100.0%), 192 (54.2%), 127 
(25.5%); Anal calcd C10H16N4O (208.26) C, 57.67; H, 
7.74; N, 26.90; Found C, 57.70; H, 7.76; N, 26.88;  
5-amino-N-cyclohexyl-1-phenyl-1H-pyra-
zole-4-carboxamide (5b)  yield 80%; mp=240-242 
oC ; IR (KBr) νmax/cm-1: 1646 (C=O),  3409 (NH), 
3336 (NH2), cm-1; 1H NMR (DMSO-d6): δ1.3-1.8(m, 
10H, H2C), 3.53(s,1H, HC-NH), 6.37 (s,2H, H2N-
D2O-exchangable), 7.48-7.54(m,5H, HAr,s), 7.85 (s,1H, 
HN D2O-exchangable), 7.96(s, 1H, HC);13C NMR 
(300MHz- DMSO-d6) d 22.9 (CH2), 28 (CH2), 33.8 
(CH2), 47.1 (CH), 120.2 (CH), 126.3 (CH), 129.3 (CH), 
129.4 (CH), 139.7 (CH), 140.6 (CH=), 142 (CH=), 150.1 
(CH=), 167.3 (C=O); MS m/z (%) 186 (M+, 100.0%), 284 
(27.5%), 241 (12.3%), 120(10.6%); Anal calcd C16H20N4O 
(284.36) C, 67.58; H, 7.09; N, 19.70; Found C, 67.63; H, 
7.12; N, 19.76.
5-amino-N-cyclohexyl-1-phenylsul-
phone-1H-pyrazole-4-carboxamide (5c) yield 80%; 
mp=200-202 oC ; IR (KBr) νmax/cm-1:  1646  (C=O), 
3409 (NH), 3359 (NH2) cm-1; 1H NMR (DMSO- d6): 
d1.3-1.8(m, 10H, H2C), 3.53(s,1H,HC-NH) , 6.42 
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(s, 2H, H2ND2O-exchangable), 7.54(m, 3H, HCH), 
7.66(s, 1H, HCH) 7.85 (s, 1H, HNH),  7.93(d, 2H, HC, 
J=6Hz);13C NMR (300MHz- DMSO-d6):d 22.9 (CH2), 
28 (CH2), 33.8 (CH2), 47.1 (CH), 128.3 (CH), 129.8 
(CH), 133.2 (CH), 133.8 (CH), 137.9 (CH), 139.4 (CH2), 
167.3(C=O); MS m/z (%) 250 (M+, 100.0%), 348 (30.2%) 
; Anal calcd C16H20N4O3S (348.42) C, 55.16; H, 5.79; N, 
16.08; S, 9.20 Found C, 55.21; H, 5.76; N, 16.0; S, 9.24.
Reactivity of (E)-2-cyano-N-cyclohexyl-3-(di-
methylamino) acrylamide (4) towards guani-
dine nitrate
Thermal method: To a mixture of Enaminonitrile 
4 (0.44g, 2 mmol) and the guanidine nitrate (0.222g, 
2.0 mol), dissolved in isopropyl alcohol (30ml) 
anhydrous potassium carbonate (0.552g, 4 mmol) 
was added. The reaction mixture was refluxed for 
6h and observed by TLC and then allowed to cool 
at room temperature and diluted with water (20ml), 
and washed with water and dried. Recrystallization 
from ethanol afforded compound 7
Microwave method: Enaminonitrile (0.44g, 2 mmol) 
and the guanidine nitrate (0.222g, 2.3 mol), in isopro-
pyl alcohol (30 ml) anhydrous potassium carbonate 
(0.552 g, 4 mmol) was added. The reaction mixture 
was mixed in an HP-500 Plus process vessel. The ves-
sel was capped properly and irradiated by microwaves 
under pressurized conditions (17.2 bar, 130oC) for a 
specified 20 minutes (examined by TLC), and left to 
cool at room temperature and pour on ice so the solid 
product was designed and then collected by filtration 
and washed with water and dried. Recrystallization 
from ethanol to afforded 2,4-diamino-N-cyclohex-
ylpyrimidine-5-carboxamide (7) in 60% yield ; 
m.p =216-217 o C; IR KBr) νmax/cm-1: 1650 (C=O), 
3679   (NH), 3347 (NH2), cm-1; 1H NMR (DMSO-d6): 
d 1.4-1.7 (m, 10H, H2CH2), 3.53(s, 1H,HC-NH) , 
5.32 (s, 2H, H2N D2O-exchangable) 6.21(s,2H, H2N 
D2O-exchangable), 7.9 (s,1H, HN D2O-exchangable), 
8.14(s, 1H, HC); 13C NMR (300MHz, DMSO-d6) d 
22.9(CH2), 28(CH2), 33.8(CH2), 47.1(CH), 102.1(CH), 
157.2 (CH=), 160.5 (CH=), 162.9 (C=N), 167.3 (C=O) ; 
MS m/z (%)  235 (M+, 100.0%), 219 (45.3%), 203 (30.5%) 
;Anal calcd C11H17N5O  (235.29) C, 56.15; H, 7.28; N, 
29.77; Found  C, 56.19; H, 7.30; N, 29.80.
Reaction of Enaminonitrile 4 with heterocy-
clic amine 9(a-f), 12 and 14:
Thermal method: Enaminonitrile 4 (0.44g, 2mmol) 
and the appropriate heterocyclic amine 9 (a-f), 12 
and 14 (2 mmol) in pyridine (15 ml).The reaction 
mixture was refluxed for 4h, then left to cool at room 
temperature .the precipitated product was filtered 
off, washed with ethanol dried and finally recrystal-
lized from ethanol to afford the corresponding prod-
ucts 9(a-f), 12 and 14; respectively.
Microwave method: Mixture of compound 4 
(0.44g, 2mmol) and the appropriate heterocyclic 
amine 9 (a-f), 12 and 14 (2mmol) in pyridine (15ml), 
the reaction mixture was mixed in a HP-500 Plus 
process vessel. The vessel was capped properly and 
irradiated by microwaves under pressurized condi-
tions (17.2 bar, 130oC) for a given 20 min (examined 
by TLC), and left to cool at room temperature the 
precipitated product was filtered off , washed with 
ethanol dried and finally recrystallised from ethanol 
to afford the corresponding products 9 (a-f) ,12 and 
14; respectively.
7-amino-N-cyclohexyl-2-methyl-3-phenylpyr-
azolo [1,5-a]pyrimidine-6-carboxamide (9a): 
yield 70% mp =212-214 oC ; IR (KBr) νmax/cm-1:  1648 
(C=O), 3340  (NH),  3262(NH2), cm-1; 1HNMR 
(DMSO d6): d1.3-1.8 (m, 10H, H2C), 2.79(s,3H, 
H3C), 3.53(s, 1H, HC-NH), 7.32-7.48(m, 5H, HAr,s), 
7.91 (s,1H, HN) 8.42 (s, 2H, H2ND2O-exchangable), 
9.21(s, 1H, HC); 13C NMR (300MHz-DMSO-d6): d 
17.2 (CH3), 22.9 (CH2), 28 (CH2), 33.8 (CH2),  47.1 
(CH), 112.7 (CH), 125.7(CH), 127.5 (CH), 128.8 (CH), 
129.3 (CH), 133.2 (CH), 136.4 (CH), 138.4 (CH), 161.4 
(CH=), 167.3 (C=O), 169 (CH=); MS m/z (%) 349 (M+, 
100.0%), 272 (25.7%); Anal calcd C20H23N5O (349.43) 




 85%; mp= 252-254 oC ; IR (KBr) νmax/cm-1: 1652 (C=O), 
3340(NH), 3262(NH2)cm-1; 1H NMR(DMSO-d6): 
d1.3-1.8(m, 10H, H2C), 2.79(s, 3H, H3C), 3.53(s, 1H, 
HC-NH), 6.06 (s, 1H, HC), 7.98 (s, 1H, HN), 8.42(s, 
2H, H2ND2O-exchangable), 9.05(s, 1H, HC); 13C 
NMR (300MHz-DMSOd6): d 11.1 (CH3), 22.9 (CH2), 
28 (CH2), 33.8 (CH2), 47.1 (CH), 112.7 (CH), 115.6 
(CH), 132.7 (CH), 132.9 (CH), 161.4 (CH=), 167.3 
(C=O), 171.2 (CH=); MS m/z (%)273 (M+, 100.0%), 
257 (26.9%) ; Anal calcd C14H19N5O (273.33) C, 61.52; 
H, 7.01; N, 25.62; Found C, 61.56; H, 7.05; N, 25.67; 
7-amino-3-(aza-2-chlorophenyl)-N-
cyclohexylpyrazolo[1,5-a]pyrimidine-6-
carboxamide (9c):  yield 75%; mp= 230-231 oC ; IR 
(KBr) νmax/cm-1:  1652 (C=O),   3340(NH), 3262(NH2) 
cm-1; 1H NMR (DMSO -d6): d 1.3-1.84 (m, 10H, 
H2C), 3.59 (s, 1H, HC-NH), 6.60 (s, 1H, HC), 7.18 (m, 
1H, HC), 7.31 (t, 1H, HC, J=6Hz), 7.40 (d, 1H, HC, 
J=10.2Hz), 7.81(s, 1H, HN), 7.84 (d, 1H, HC, J=6Hz), 
8.74 (s, 2H, H2N D2O-exchangable), 8.99 (s, 1H, 
HC); 13C NMR (300MHz- DMSOd6): d 22.9 (CH2), 
33.8 (CH2),  47.1 (CH), 105 (CH), 112.7 (CH), 126.9 
(CH), 128.1(CH), 128.9 (CH), 129 (CH),133 (CH), 
134.3 (CH), 161.4 (CH=), 167.3(C=O); MS m/z (%) 
397 (M+, 100.0%), 399 (32.5%), 120(18.7%);Anal calcd 
C19H20ClN7O (397.86)  C, 57.36; H, 5.07, Cl, 8.91; N, 
24.64; ; Found C, 57.32; H, 5.11; Cl, 8.89; N, 24.67; 
7-amino-3-(4-bromophenyl)-N-
cyclohexylpyrazolo[1,5-a]pyrimidine-6-
carboxamide (9d): yield 71% mp=<300 oC ; IR (KBr) 
νmax/cm-1:  1652 (C=O), 3340  (NH), 3262(NH2) cm-
1; 1H NMR (DMSO-d6): d1.3-1.84 (m, 10H, H2C), 
3.59(s, 1H, HC-NH), 7.37(d,2H, HC, J=6.1Hz), 7.49 
(d, 2H, HC,), 8.03(s, 1H, HN), 8.40(d, 1H, HC, 
J=8.6Hz), 8.74(s, 2H, H2ND2O- exchangable), 9.06 
(s, 1H, HC);13C NMR(300MHz-DMSO-d6): d 22.9 
(CH2), 33.8 (CH2),  47.1 (CH), 97(CH) , 112.7 (CH), 
123.1 (CH), 129.7 (CH), 129.7 (CH), 130.7 (CH), 
132.2 (CH), 135.4 (CH), 161.4 (CH=), 168 (C=O), 169 
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(CH=); MS m/z (%) 413 (M+, 100.0%), 415 (97.3%), 67 
(38.3%) ; Anal calcd C19H20BrN5O (414.3) C, 55.08; H, 




(9e): yield 75% mp= <300 oC ; IR (KBr) νmax/cm-
1: 1652 (C=O), 3340 (NH), 3262 (NH2) cm-1; 1H 
NMR (DMSO-d6): d1.3-1.84 (m, 10H, H2C), 3.59(s, 
1H, HC-NH), 3.73(s, 3H, H3OC),6.83 (d, 2H, HC, 
J=6.1Hz), 7.37 (d, 2H, HC, J=6.1Hz), 8.09 (s, 1H, HN), 
8.40 (d, 1H, HC, J=12.1Hz), 8.74 (s, 2H, H2ND2O-
exchangable), 9.05(s, 1H, HC); 13C NMR (300MHz- 
DMSOd6): d 22.9 (CH2), 28 (CH2), 33.8 (CH2), 47.1 
(CH), 55.9 (CH3),97 (CH), 112.7 (CH), 114.8 (CH), 
128.5 (CH), 128.7 (CH), 130.4 (CH), 130.8(CH), 
160.7(CH), 161.4(CH=), 169.3(C=O),171(CH=); MS 
m/z (%) 365.14 (M+, 100.0%), 366 (22%); Anal calcd 
C20H23N5O2 (365.43) C, 65.73; H, 6.34; N, 19.16; 
Found C, 65.76; H, 6.35; N, 19.19;
7-amino-2-bromo-N-cyclohexyl-3-
phenylpyrazolo[1,5-a]pyrimidine-6-
carboxamide (9f): yield 75%; mp= 224 oC ; IR (KBr) 
νmax/cm-1:  1652 (C=O), 3340(NH), 3262(NH2) cm-
1; 1H NMR (DMSO-d6): d 1.3-1.84 (m, 10H, H2C), 
3.59(s,1H, HC-NH), 7.22(m, 1H, HC), 7.32(d, 2H, 
HC, J=6.1Hz), 7.84(d, 2H, HC, J=6.1Hz), 7.91(s, 1H, 
HN), 8.78 (s, 2H, H2ND2O-exchangable), 9.01(s, 1H, 
HC); 13C NMR (300MHz-DMSO-d6): d 22.9(CH2), 
28(CH2), 33.8(CH2), 47.1(CH), 112.7(CH), 117.1(CH), 
127.5(CH), 128.8(CH), 129.3(CH), 129.8(CH),131(CH), 
136.4(CH), 162.1(CH=), 169(C=O), 172(CH=); MS 
m/z (%) 413.09 (M+, 100.0%), 315 (97.3%); Anal calcd 
C19H20BrN5O (414.3) C, 55.08; H, 4.87; Br, 19.29; N, 
16.90; Found C, 55.11; H, 4.89; Br, 19.33; N, 16.88;
5-amino-N-cyclohexyl-[1,2,4]triazolo[4,3-a]
pyrimidine-6-carboxamide 12: yield 70% mp = 
290-292 oC ; IR (KBr) νmax/cm-1:  1662 (C=O), 3430 
(NH), 3274  (NH2) cm-1; 1HNMR (DMSO-d6): d1.3-1.8 
(m, 10H, H2C), 3.53(s, 1H, HC-NH), 7.91(s, 1H, HN), 
8.22(s, 1H, HC), 8.46 (s, 2H, H2ND2O-exchangable), 
9.26 (s, 1H, HCH); 13C NMR(300MHz, DMSO-d6): 
d 22.9 (CH2), 28 (CH2), 33.8 (CH2),  47.1(CH), 112.7 
(CH), 139.7 (CH), 152.8 (CH=), 160.4 (CH=), 168.3 
(C=O), 170(CH); MS m/z (%) 162 (M+, 100.0%), 260 
(95%), 178 (63.5%),  ;    Anal calcd   C12H16N6O (309.37) 




14: 75% yield mp = <300 oC ; IR (KBr) νmax/cm-1: 
1656 (C=O), 3347(NH), 3266 (NH2) cm-1; 1H NMR 
(DMSO-d6): d 1.3-1.8 (m, 10H, H2C), 3.8(s, 1H, 
HCH-NH), 7.36 (t, 2H, CH, J=2.7Hz), 7.75(d, 2H, HC, 
J=2.8Hz), 8.04 (s, 1H, HN), 8.44 (s, 2H, H2ND2O-
exchangable), 9.26 (s, 1H, HC); 13CNMR (300MHz, 
DMSO-d6): d 22.9 (CH2), 28 (CH2), 33.8 (CH2),  47.1 
(CH), 112.7 (CH) ,115.3 (CH), 123 (CH), 135.2 (CH), 
138.9 (CH), 150 (CH=), 168.3 (C=O), 169 (CH=); MS 
m/z (%) 309 (M+, 100.0%), 211(79.4%) ,310(26.6%), 
Anal calcd C17H19N5O (309.37) C, 66.00; H, 6.19; N, 
22.64;  Found C, 66.09; H, 6.22; N, 22.68; 
RESULTS AND DISCUSSION
Chemistry
The reaction between cyclohexylamine and ethyl 
cyanoacetate without solvent under microwave irra-
diation afforded the corresponding 2-cyano-N-cy-
clohexyacetamide (3) in excellent yield. Solvent-free 
synthesis of (E)-2-cyano-N-cyclohexyl-3-(dimethyl-
amino)acrylamide as a versatile cyclohexyl-containing 
building block has been accomplished by microwave 
irradiation of a (4) 2-cyano-N-cyclohexyacetamide (3) 
with dimethylformamide-dimethylacetal (DMF-DMA) 
(Scheme 1). IR spectrum revealed to three absorption 
bands at 3342, 2186 and 1656  cm-1 due to NH, CN, 
C=O, respectively. Its 1H NMR revealed signals at δ 
3.09 and at δ 7.66 due to N, N-dimethyl amino and  CH 
proton, respectively, in addition to an aliphatic multi-
plied in the region δ 1.4-1.7. Its mass spectrum revealed 













































































Scheme 2. Reaction of Enaminonitrile 4 with hydrazine hydrate derivatives and guanidine
Scheme 1. Synthesis of (E)-2-cyano-N-cyclohexyl-3-
(dimethylamino)acrylamide (4)
The reactivity of enaminonitrile 4 towards some nitro-
gen nucleophiles was investigated. Thus, treatment of 
compound 4 with hydrazine hydrate, phenylhydrazine 
derivatives in refluxing isopropyl alcohol furnished the 
novel pyrazoles 5a-c as displayed in scheme 2. The IR 
spectra of compound 5a-c were free of Nitrile function 
and showed the absorption band for NH and NH2 in the 
region 3409-3336 cm-1. The formation of compounds 
5a-c is assumed to take place via a Michael-type ad-
dition of the amino group of hydrazines to enaminone 
double bond in (E)-2-cyano-N-cyclohexyl-3-(dimethyl-
amino) acrylamide monitored by loss dimethylamine 
(scheme 2). In the same manner, the enaminonitrile 4 
reacts with guanidine in refluxing isopropyl alcohol to 
provide a high yield of a single product (as examined by 
TLC). That was identified as 2,4-diamino-N-cyclohex-
ylpyrimidine-5-carboxamide (7) permitting to its ele-
mental and spectral analysis (c.f. Experimental part).
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Scheme 2. Reaction of Enaminonitrile 4 with hydrazine hydrate derivatives and guanidine 
Scheme 3. Reaction of Enaminonitrile 4 with 5-amino pyrazole derivatives 8a-f 
Scheme 2. Reaction of Enaminonitrile 4 with hydrazine 
hydrate derivatives and guanidine
The reactivity of (E)-2-cyano-N-cyclohexyl-3-(dimeth-
ylamino) acrylamide (4) towards some heterocyclic 
amines was also investigated. Thus, when compound 4 
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was treated with 5-amino pyrazole derivatives 8a-f in 
pyridine it furnished in each example, a single products 
were identified as pyrazolo[1,5-a]pyrimidine derivatives 
9a-f, The structure 9a was achieved by independent syn-
thesis of compound 9a via reaction of 5-N-(N,N-dimeth-
ylaminomethylene) imino3-phenyl-1H-pyrazole with 
2-cyano-N-cyclohexy acetamide 3 in refluxing ethanol 
and the presence of catalytic amount of piperidine that 
afforded a product identical in all respects (mp.; TLC and 
spectra) with that achieved from of the Enaminonitrile 4 
and 5-aminopyrazoles derivatives 8a-f (Scheme 3)
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Scheme 3. Reaction of Enaminonitrile 4 with 5-amino 
pyrazole derivatives 8a-f
In a similar manner, compound 4 reacted with 
3-amino-1,2,4-triazole (11) to afford triazole [4,3-a] 
pyrimidine derivatives (scheme 4).The mass spectrum 
of the isolated product revealed a peak at m/z 309 cor-
responding to its molecular ion. It’s an IR spectrum 
reveled two characteristic bands in the region 3430-
3274cm-1 due to NH and NH2 and band at 1662  cm-1 
due to the carbonyl group and no absorption band for 
Nitrile-function.
Finally, the Enaminonitrile 4 reacts with 2-amin-
obenzimidazole (13) to give 4-amino-N-cyclohex-
yl-4,6-dihydropyrimido[1,2-b] indazole-3-carbox-
amide 14 (Scheme 4). The structure of the isolated 
product was confirmed on the basis of the elemental 













































































































Scheme 4. Reaction of Enaminonitrile 4 with 3-amino-1,2,4-triazole and 2-aminobenzimidazole
Scheme 4. Reaction of Enaminonitrile 4 with 3-ami-
no-1,2,4-triazole and 2-aminobenzimi azole
Table. 1 Optimized bond length Å, and bond and dihedral angle degrees 
of Compounds 5a and 9a via DFT B3LYP/6-31G(d)
Compound 5a Compound 9a
Parameters of bond lengths Å Parameters of bond angles Degrees Parameters ofbond lengths Å Parameters of bond angles Degrees
C23-N27 1.3836 N27-C23-N30 122.8540 N28-N30 1.3699 C3-N17-C20 126.0873
C20-O21 1.2557 C23-N30-N31 113.8049 N30-C32 1.3620 N30-N28-C23 123.5823
N30-N31 1.3756 C24-N31-N30 106.9212 N17-C3 1.4709 N25-C23-N28 116.5805
C24-C22 1.5270 N18-C20-O21 120.6569 C20-O19 1.2771 C31-C24-N29 131.6775
C22-C23 1.5174 H29-N27-C23 116.4661 N29-C22 1.4947 N28-C24-N29 123.6158
N30-H26 1.0052 H19-N18-C20 113.7350 N29-C24 1.3177 N17-C20-C21 117.5352
N27-H28 1.0095 N18-C2-C3 111.6088 C24-N23 1.4136 C2-C3-N17 110.8324
N18-H19 1.0146 C1-C2-C3 111.4826 N28-C23 1.3902 C38-C39-C40 117.7719
N18-C20 1.0690 C1-C2-C6 111.4599 C23-C21 1.3872 C23-N25-H27 119.5643
N18-C3 1.4717 C3-C4-C5 111.6289 N28-N30 1.3699 O19-C20-C21 123.3318
C2-C3 1.5466 H29-N27-C23-N30 118.4812 C23-N25 1.3485 O19-C20-N17-H18 2.5675
C3-C4 1.5444 C22-C23-N30-N31 -1.7765 C31-C39 1.4615 N25-C23-C21-C20 -4.0106
N18-H19 1.0147 C22-C24-N31-N30 0.4818 C33-C32 1.4969 N30-N28-C24-N29 179.7452
C3-H17 1.0947 N18-C20-O21-C22 179.3091 C2-C3 1.5456 N28-C24-N29-C22 5.11674
Table 2 Energetics of the ground state of 5a and 6a using DFT B3LYP/6-31G(d)
Compound 5a Compound 6a
ET (au) -685.2566 ET (au) -685.20751
EHOMO (au) -0.23880 EHOMO (au) -0.22029
ELOMO (au) -0.18299 ELOMO (au) -0.15414
Eg (eV) 1.51866 Eg (eV) 1.800034





N30 -0.448 N30 -0.392
N31 -0.147 N29 -0.253
N18 -0.546 N18 -0.640
O21 -.0436 O21 -0.477
H19 0.302 H19 0.318
C20 0.563 C20 0.561
C3 -0.032 C3 0.044
C24 0.002 C24 0.034
a Eg= ELOMO - EHOMO.
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MOLECULAR ORBITAL 
CALCULATIONS
Geometrical optimization of compounds 5a and 
9a proceeded at DFT/B3LYP hypothesis utilizing 
the Gaussian 09W program38,39, which explain why 
(E)-2-cyano-N-cyclohexyl-3-(dimethylamino)acryla-
mide (4) reacted with hydrazine hydrate, as repre-
sentative examples of nucleophilic reagent, to yield 
the corresponding novel pyrazoles 5a-c   with excel-
lent yield rather than compound 6a-c. On the other 
hand, the cyclization of acrylamide 4 with 5-amino 
pyrazole derivatives 8a-f did not lead to the forma-
tion of a pure sample of the corresponding pyra-
zole[1,5-a] pyrimidine derivatives 9a-f. Furthermore, 
DFT calculation was employed to study the stability 
of the pyrazole 5a and pyrazolo[1,5-a] pyrimidine 
9a are both have 1H-pyrazole moiety, neverthe-
less they differ in the arrangement of the rings with 
pyrazole moiety with respect to the pyrazole  5a or 
pyrazolo [1,5-a] pyrimidine 9a rings. The optimized 
geometries (bond lengths and bond angles) as well 
as ground state energies total energy ET, energy of 
highest occupied MO EHOMO, energy of lowest unoc-
cupied MO ELUMO, energy gap Eg, dipole moment µ, 
and net charge on pyrazole 5a and pyrazolo [1,5-a]
pyrimidine 9a rings using DFT/B3LYP/6-31G(d) are 
presented in Table 1, Table 2 , Figure. 2 and Figure 3
From the results of Table 1, Table 2 and Figure. 2 and 
Figure 3, the following conclusions were concluded:
(1)- The optimized bond length of both pyrazole 5a 
is fall in range 1.0052 to 1.5444 the same agreement 
with experimental40 also pyrazolo [1,5-a] pyrimi-
dine 9a falls in the range from 1.3177 to 1.5456 Å 
which are in good agreement with the experimental 
data 1.3601-1.7830 Å41, for C=O bond of pyrazoles 
derivatives the optimized length obtained by B3LY-
P/6-31G(d) is 1.2557 Å were slightly longer than the 
experimental value 1.2307 Å42 .
(2)- The bond angles for DFT/ B3LYP/6-31G (d) de-
scribed in Table 1 For both pyrazole 5a and amino 
pyrazolo[1,5-a] pyrimidine 9a, the two compounds 
are nonplanar, where both the pyrazole are out of the 
molecular plane.
(4) For pyrazole 5a, the pyrazole are out of the mo-
lecular plane by -1.7765(C22-C23-N30-N31) and 
-0.4818(C22-C24-N31-N30); respectively, which per-
mit the interaction with the appropriate hydrazine 
hydrate to afford the corresponding target molecule, 
compound 5a (85%).
(5) For amino pyrazolo [1,5-a] pyrimidine 9a, the 
pyrazol[1,5-a] pyrimidine was out of the molecu-
lar plane by -4.0106(N25-C23-C21-C20) and 5.1167 
(N28-C24-N29-C22), respectively, which lead to sta-
bility between phenylpyrazolo[1,5-a]pyrimidine and 
cyclohexyl ring.
From the above results (1–5), it is clear that as the 
pyrazole 5a and pyrazolo [1,5-a] pyrimidine 9a, orig-
inated close to the molecular plane of the pyrazole 
moiety. On the other hand, as the two compounds, 
5a and 9a moieties go far from the molecular plane 
of the pyrazole ring, by increasing its dihedral angles.
(6) The two p-isoelectronic structures 5a and 6a 
are different in order of stability, even though 1H-
pyrazole 5a seems a more stable than pyrazole 6a by 
0.2814 eV (≈27. 148 kcal).
(7) From the calculations of the energy gap, Eg, 
which measure the chemical activity, pyrazole 5a 
was found to be more reactive than amino pyrazole 
6a by -685.257 kcal.
(8) The polarity or charge separation over the mol-
ecule, which is measured by the dipole moment µ, 
showed that µ of pyrazole 5a < µ of pyrazole 6a by 
2.0191D as displayed in Table 2. 
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Figure.2 Optimized geometry and numbering system, of 5a and 6a utilizing DFT B3LYP/6-
31G(d)
9)  The energies of the  π-isoelectric compounds 7-amino-N-cyclohexyl-2-methyl-3-phenyl 
pyrazolo[1,5-a]pyrimidine-6-carboxamide (9a) and 5-amino-N-cyclohexyl-2-methyl-3-
phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide (10a) are different in  order of stability as 
shown in Table 3, even though phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide 9a seems a 
more stable than phenylpyrazolo[1,5-a]pyrimidine-6-carboxamide 10a by 0.4269 eV (≈41.1941 
kcal).
(10)- Energy gap, Eg calculations measure the chemical activity, phenylpyrazolo[1,5-a]
pyrimidine-6-carboxamide 9a was found to be more reactive than amino phenylpyrazolo[1,5-
a]pyrimidine-6-carboxamide 10a by -1124.049 kcal.
(11) Dipole moment µ (Charge separation polarity) of pyrazolo[1,5-a]pyrimidine 9a < µ of 
pyrazolo[1,5-a]pyrimidine 10a by 2.8866D.
Table 3 Energetics of the ground state of 9a and 10a using DFT B3LYP/6-31G (d)
Compound 9a Compound 10a
ET (au) -1124.049 ET (au) -1123.2926
EHOMO (au) -0.21096 EHOMO (au) -0.19870
ELOMO (au) -0.18885 ELOMO (au) -0.16090
Eg (eV) 0.601644 Eg (eV) 1.028591
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Table 3 Energetics of the ground state of 9a and 10a using DFT B3LYP/6-31G (d)
Compound 9a Compound 10a
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EHOMO (au) -0.21096 EHOMO (au) -0.19870
ELOMO (au) -0.18885 ELOMO (au) -0.16090
Eg (eV) 0.601644 Eg (eV) 1.028591
Figure.2 Optimized geometry and numbering system, of 
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(9) The energ es of the π-isoelectric compounds 
7-amino-N-cyclohexyl-2-methyl-3-phenyl pyra-
zolo[1,5-a]pyrimidine-6-carboxamide (9a) and 
5-amino-N-cyclohexyl-2-methyl-3-phenylpyra-
zolo[1,5-a]pyrimidine-6-carboxa ide (10a) are dif-
ferent in  order of stability as shown in Table 3, even 
though phenylpyrazolo[1,5-a]pyrimidine-6-carbox-
amide 9a seems a more stable than phenylpyra-
zolo[1,5-a]pyrimidine-6-carboxamide 10a  by 0.4269 
eV (≈41.1941 kcal).
(10)- Energy gap, Eg calculations measure the 
i al activity, phenylpyraz lo[1,5-a] pyrimi-
dine-6-carboxamide 9a was found to be more re-
active than amino phenylpyrazolo[1,5-a]pyrimi-
dine-6-carboxamide 10a by -1124.049 kcal.
(11) Dipole moment µ (Charge separation polar-
ity)  of pyrazolo[1,5-a]pyrimidine 9a < µ of pyra-
zolo[1,5-a]pyrimidine 10a by 2.8866D.
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Figure.3 Optimized geometry and numbering system of 9a and 10a using DFT B3LYP/6-
31G(d)
From results (6-11) we established that Compounds amino-N-cyclohexyl-1H-pyrazole 
derivatives 5a and 6a are the p-isoelectronic molecule, as outlined in Scheme 2, compound 5
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Table 3 Energetics of the ground state of 9a and 10a using 
DFT B3LYP/6-31G (d)
Compound 9a Compound 10a
ET (au) -1124.049 ET (au) -1123.2926
EHOMO (au) -0.21096 EHOMO (au) -0.19870
ELOMO (au) -0.18885 ELOMO (au) -0.16090
Eg (eV) 0.601644 Eg (eV) 1.028591





N28 -0.698 N25 -0.604
N29 -0.368 N27 -0.168
C20 0.486 C28 -0.062
O19 -0.541 O19 -0.466
N25 -0.775 N45 -0.598
C23 0.607 C23 0.278
C21 0.043 C21 -0.075
C32 0.225 C29 0.206
a Eg= ELOMO - EHOMO.
From results (6-11) we established that Compounds 
amino-N-cyclohexyl-1H-pyrazole derivatives 5a and 
6a are the p-isoelectronic molecule, as outlined in 
Scheme 2, compound 5 can be obtained using alter-
native pathway. DFT calculations at the same level 
of theory DFT B3LYP/6-31G(d) for both p-isoelec-
tronic structures 5a and 9a were performed. The ge-
ometry and ground state energies of both structures 
are presented in Table 1, Table 2 and Table 3 and 
Fig re. 2 and Figure 3 the results of DFT calcula-
tions predicted that structure 5a is more stable than 
structure 6a by only ≈ 27.1 kcal. It is also establish 
that the structure 9a is more chemically active than 
structures 10a by only ≈ 41.1941 kcal. This implies 
that the two structures have almost the same order 
of stability, reactivity and both can chemically exist.
Vibrational assignment and 1H NMR and 13C 
NMR calculations of compound 9a
The optimized structure phenylpyrazole[1,5-a] 
pyrimidine-6-carboxamide 9a is displayed in Fig-
ure.2, and selected bond lengths, bond angles, and 
Table 4. Comparison of the experimental and calculated vibrational frequencies and 1H NMR and 13C NMR calculations of 9a.
Compound 9a




























ν (NH) 3463.23 3340. 22 H10 1.3121 0.7254 1.4409 C1 17.212 17.3982 34.9180
ν(NH2) 3252.23 3262.51 H12,13,15 1.4921 0.8285 1.5440 C4 22.932 23.0156 40.5352
ν (=CH-H) 3086.28 3073.21 H7 1.5230 0.9491 1.6646 C2 28.102 36.6616 54.1812
ν (=C-H) 3029.88 3011.10 H11 1.5520 1.0554 1.7709 C3 33.825 45.7590 63.2790
ν (C-H) 2893.23 2811.32 H35,36 2.7903 1.6269 2.3424 C22 47.134 56.5303 74.0494
ν (C=O) 1693.23 1648.25 H9 1.8233 1.6923 2.4078 C21 112.723 76.1330 93.6533
H34 2.7901 1.9200 2.6355 C31 125.701 107.7100 125.2900
H16 2.0234 2.1808 3.5263 C42 127.512 111.9560 129.4752
H18 3.5301 3.3156 4.0311 C37 128.802 112.0402 129.5590
H48 7.3212 4.0991 4.8146 C38 129.314 112.2100 129.7297
H27 8.4202 4.2394 3.9541 C41 133.225 112.3809 129.9006
H47 7.3514 6.5096 7.2251 C40 136.432 113.6583 131.1783
H46 7.3403 6.5609 7.2764 C39 138.442 117.0133 134.5327
H43 7.4481 6.6362 7.3517 C23 139.311 126.1023 143.6221
H44 7.4820 6.8263 7.5418 C24 161.401 138.6373 156.1572
H26 8.4201 7.2351 7.9506 C32 167.300 140.8723 158.3872
H45 9.2111 7.7370 8.4526 C20 169.0231 153.1230 170.6722
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dihedral angles are scheduled in Table 1 designed 
by B3LYP/6-31G(d). IR frequencies of compound 
9a were calculated using the DFT/B3LYP methods 
with the 6-31G(d) basis set. The vibrational band 
assignments were made using the Gauss-View mo-
lecular visualization program. Table 4 shows the 
observed and calculated IR spectra of this com-
pound. Calculated vibrational frequencies of 9a at 
DFT/B3LYP levels were scaled by 0.96 and 0.89; re-
spectively43. The IR spectra have some characteristic 
bands of stretching vibrations of NH, NH2, =CH-H, 
=C-H, C-H, and C=O. The structure that contains 
NH displays stretching vibrations of NH in the re-
gion 3300-3500 cm-1 45. The NH and NH2 stretching 
mode observed at 3340.2, 3262 cm-1experimentally; 
respectively, and calculated at 3463.23, 3252.23cm-
1 for B3LYP. The aromatic structure displays the 
presence of =CH-H stretching vibrations in the 
region 3000-3100 cm-1 44 was observed at 3073.21 
cm-1 experimentally and calculated at 3086.28 cm-1 
for B3LYP. Moreover, The C=O absorption band 
appears in 1648 cm-1 experimentally and 1693.23 
cm-1 for B3LYP (Table 4). As can be seen from a 
correlation graph in Figure. 2 experimental data 
are found to require a better correlation for B3LYP 
Moreover; the vibrational frequencies calculated 
by the B3LYP method are more compatible to ex-
perimental values. Furthermore 1H and 13C NMR 
chemical shift calculations using the density func-
tional theory-gauge including/invariant atomic 
orbitals (DFT-GIAO) and (HF-GIAO)  approxima-
tions at the B3LYP/6-31G (d) level of theory, which 
were comparable  with the experimental 1H and 13C 
chemical shift values for 9a as displayed in Table 4 
,which showed the proton chemical shift values are 
considered to be 0.72540-7.73700 ppm using B3LY-
P/6-31G (d) and 1.4409-8.4526 ppm using HF/6-31G 
(d), while the experimental results are observed to 
be 1.312-9.211 ppm. The atoms were numbered as 
in Figure. 2. The theoretical result is in agreement 
with the experimental data, except the NH2 proton 
(H27 and H26). This proton performs at 8.420 ppm 
and is shifted towards higher magnetic field than 
the calculated one by B3LYP/6-31G (d) and HF/6-
31G (d). The difference between the calculated and 
the experimental data for proton (H27 and H26) is 
4.2394, 3.954 and 7.2351, 7.9506 ppm for B3LYP and 
HF; respectively. The continuum solvation models 
are important computational methods for theoret-
ical studies such as conductor-like polarizable con-
tinuum model (CPCM) used for compute aqueous 
solvation free energies for a number of organic mol-
ecules 45a,b, but this model fails in reproducing the 
experimental results for the hydrogen-bonded pro-
tons and specific solute-solvent interactions which 
thoroughly expected to explain the NMR spectra 
of compound 9a. The calculated 13C NMR and the 
experimental outcome are scheduled in Table 4. As 
can be seen, the agreement with experimental data 
is good. The largest differentiation in 13C chemical 
shifts observed for C(21), C(31), C(42), C(38), C(41), 
(C37) and C(32), using B3LYP/6-31G(d), while the 
largest differentiation observed for C (1), C(4), C(3), 
C(22), C(23) and C (24), using HF/6-31G(d) method. 
As can be seen from Table 4, the theoretical 1H and 
13C chemical shift results for 9a are generally closer 
to the experimental 1H and 13C shift data.
Frontier Molecular Orbitals of compound 9a:
FMO (Frontier molecular orbital) is a powerful 
guiding approach in the electrical and optical prop-
erties, in addition to UV-Vis spectra and chemical 
reactions. The highest occupied molecular orbital 
(HOMO) acts as an electron donor and the lowest 
unoccupied molecular orbital (LUMO) acts as the 
electron acceptor. The energy gap between HOMOs 
and LUMOs connected to the biological activity 
of the molecule. Moreover, it helps in characteriz-
ing the chemical reactivity and kinetic stability of 
the molecule. A large energy gap between HOMO-
LUMO represents the high kinetic stability. Figure. 
4 indications the distributions and energy levels of 
the HOMO, LUMO, and orbitals computed at the 
TD-DFT B3LYP/6-31G (d) level for 9a. The posi-
tive and negative phases are represented in red and 
green colors, respectively. As appreciated from Fig-
ure. 4, Though DFT calculates the ground states 
energetics for various materials, it be unsuccessful 
in predicting the energy gaps between occupied and 
unoccupied states which is less than the half of the 
observed value. Consequently, in order to overcome 
this problem hybrid functional was used. Gen-
eral, hybrid functional were used to improve the 
description of the ground state energies for small 
molecules46-47. One of the most commonly hybrid 
functional used is B3LYP which leads to improved 
band gaps as good as that obtained from sophisti-
cated correlated calculation48 so to  rationalized this 
increased accuracy by comparison with results from 
time-dependent DFT (TD-DFT) calculations so we 
found the HOMO–LUMO gap energy (2.2474 eV). 
This energy gap of the excited state gives the com-
pound 9a more stable49, 50 as displayed in Figure 4.
20
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CONCLUSION
Our investigation we synthesized a variability of 
fused heterocyclic systems consolidating cyclohexyl 
moiety via the reaction of (E)-2-cyano-N-cyclohex-
yl-3-(dimethylamino)acrylamide (4)  with appro-
priate 1,3-binucleophiles exhausting convention-
al procedures other than microwave irradiation. 
Furthermore, a theoretical interpretation of the 
regioselectivity of the cyclocondensation reactions 
was carried out exhausting DFT concentrated with 
DFT/B3LYP and HF methods with the 6-31G (d) 
basis set combination. Comprehensive theoretical 
and experimental structural studies pyrazolo[1,5-a]
pyrimidine 9a have been carried out by elemental 
analysis, FTIR, 1H NMR, and Mass. Optimized mo-
lecular structure and harmonic vibrational frequen-
cies have been investigated by DFT/B3LYP 6-31G(d) 
basis set.
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